Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,229 | 5,028 | 1,808 | 9 | 3,702 |
| Marketable Securities | N/A | N/A | N/A | N/A | 3,808 |
| TOTAL | $8,592 | $5,615 | $2,934 | $312 | $8,129 |
| Non-Current Assets | |||||
| PPE Net | 3 | 4 | 8 | 4 | N/A |
| Other Non-Current Assets | 71 | 120 | 14 | 67 | 206 |
| TOTAL | $74 | $124 | $22 | $71 | $206 |
| Total Assets | $8,666 | $5,739 | $2,956 | $383 | $8,335 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,837 | 897 | 1,410 | 1,294 | 918 |
| Accrued Expenses | 750 | 691 | 1,270 | 36 | 1,430 |
| Other current liabilities | N/A | N/A | 3 | 5 | 97 |
| TOTAL | $2,643 | $1,636 | $2,697 | $1,994 | $2,445 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 15 | 71 | 0 | 14 | 72 |
| TOTAL | $15 | $71 | $N/A | $14 | $72 |
| Total Liabilities | $2,658 | $1,707 | $2,697 | $2,008 | $2,517 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,445 | 19 | 1 | 13,482 | 6,813 |
| Retained earnings | -51,696 | -39,740 | -31,533 | -18,496 | -21,902 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -2 |
| TOTAL | $6,008 | $4,032 | $259 | $-1,625 | $5,818 |
| Total Liabilities And Equity | $8,666 | $5,739 | $2,956 | $383 | $8,335 |